Document And Entity Information
Document And Entity Information | Mar. 28, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 28, 2022 |
Entity Registrant Name | 4D Molecular Therapeutics Inc. |
Entity Central Index Key | 0001650648 |
Entity Emerging Growth Company | true |
Entity File Number | 001-39782 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-3506994 |
Entity Address, Address Line One | 5858 HORTON STREET |
Entity Address, Address Line Two | #455 |
Entity Address, City or Town | EMERYVILLE |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94608 |
City Area Code | 510 |
Local Phone Number | 505-2680 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | FDMT |
Security Exchange Name | NASDAQ |